What Happens After the Device IPO?
This article was originally published in Start Up
Investors love to remind everyone that IPOs are financing events, not exiting events, using the mantra to put off Judgment Day for their investments. So how have device companies fared after the recent spate of IPOs?
You may also be interested in...
A group of private enterprises are working to revive the moribund IPO market for venture-backed start-ups.
Covidien, following the acquisition of Vnus Medical Technologies and Bacchus Vascular, is establishing a global business unit focused on vascular surgery.
The directors of Northstar Neuroscience, developer of the Renova cortical stimulation system, have elected to liquidate all assets and dissolve the company